The Australian Advantage
Australia provides one of the most compelling environments globally for clinical trials, combining high quality, rapid timelines, and cost-effectiveness with a world-class clinical and medical sector.
Quality
Our tailored assay development, qualification, and validation are performed according to international regulatory FDA, EMA, ICH M10 guidelines, industry standards and project specific requirements.
Speed
For the most expeditious path into First in Human, Australia offers one of the fastest and most streamlined regulatory approval processes in the world with no IND requirement. Upon completion of nonclinical studies, biopharma can achieve clinical trial approval within 4-5 weeks.
Cost
Established since July 2011, The Australian Government’s generous Research and Development (R&D) Tax Incentive allows eligible biotechs can access up to 43.5% cash refund on R&D activities undertaken in Australia.
Tax Specialist Contacts:
Feel free to contact one of the many experienced Australian Tax Specialists to assist you through this process;
